ANALYSIS OF THE FLT3-ITO AND NPM1 MUTATIONS IN AML PATIENTS WITH INTERMEDIATE RISK RECEIVING ALLOGENEIC STEM-CELL TRANSPLANTATION

被引：0
|
作者：
Ogasawara, M. [1 ]
Yamakawa, T. [1 ]
Katsura, Y. [1 ]
Shima, K. [1 ]
Matsukawa, T. [1 ]
Kanaya, M. [1 ]
Minauchi, K. [1 ]
Nakata, M. [1 ]
Ota, S. [1 ]
Imai, K. [1 ]
Hirano, T. [1 ]
Kobayashi, N. [1 ]
Kiyama, Y. [1 ]
机构：
[1] Sapporo Hokuyu Hosp, Sapporo, Hokkaido, Japan
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
396
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [21] Simultaneous Detection of FLT3-ITD, FLT3-D835 and NPM1 Mutations in AML
    Bernardino, L. P.
    Nagy, P. L.
    Hensel, J. W.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 578 - 578
  • [22] A simple, one step assay for simultaneous detection of haematopoietic chimerism, NPM1 and FLT3-ITD mutations after allogeneic stem cell transplantation
    Waterhouse, M.
    Bertz, H.
    Finke, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S244 - S245
  • [23] Mutational status of nucleophosmin (npm1) and flt-3 genes are strong predictors of the outcome in patients with cytogenetic intermediate-risk acute myeloid leukemia undergoing autologous stem-cell transplantation
    Torrebadell, M.
    Camos, M.
    Brunet, S.
    Rozman, M.
    Pratcorona, M.
    Nomdedeu, J.
    Carrio, A.
    Costa, D.
    Colomer, D.
    Carreras, E.
    Camp, E.
    Sierra, J.
    Montserrat, E.
    Esteve, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 181 - 181
  • [24] A simple, one step assay for simultaneous detection of hematopoietic chimerism, NPM1 and FLT3-ITD mutations after allogeneic stem cell transplantation
    Waterhouse, M.
    Bertz, H.
    Finke, J.
    ONKOLOGIE, 2012, 35 : 127 - 127
  • [25] Favorable remission control by allogeneic stem cell transplantation in NPM1 positive intermediate-risk AML: Donor versus no-donor analysis of 302 patients from the SAL AML-2003 trial
    Roellig, C.
    Bornhaeuser, M.
    Thiede, C.
    Kramer, M.
    Ho, A.
    Schaefer-Eckart, K.
    Haenel, M.
    Einsele, H.
    Aulitzy, W.
    Berdel, W. E.
    Stelies, M.
    Baldus, C.
    Krause, S. W.
    Platzbecker, U.
    Schaich, M.
    Schetelig, J.
    Ehninger, G.
    ONKOLOGIE, 2012, 35 : 168 - 169
  • [26] Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
    Mona Salah
    Hamdy Zawam
    Neven Bahaa Fouad
    Nohair Soliman
    Fatma Abdel Wahab Abdel Maksoud
    Egyptian Journal of Medical Human Genetics, 22
  • [27] Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
    Salah, Mona
    Zawam, Hamdy
    Fouad, Neven Bahaa
    Soliman, Nohair
    Maksoud, Fatma Abdel Wahab Abdel
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2021, 22 (01)
  • [28] PROGNOSTIC IMPACT OF WHITE BLOOD CELL COUNT IN INTERMEDIATE RISK AML: RELEVANCE OF MUTATED NPM1 AND FLT3-ITD
    de Jonge, J. M. Hendrik
    Valk, J. M. Peter
    de Bont, S. J. M. Eveline
    Schuringa, Jan Jacob
    Ossenkoppele, Gert
    Vellenga, Edo
    Huls, Gerwin
    ANNALS OF HEMATOLOGY, 2011, 90 : S5 - S5
  • [29] Comprehensive Characterization of FLT3 and NPM1 Mutations in AML Samples Using NGS
    Xie, Z.
    Carson, A. R.
    Klass, M.
    Hubbard, D.
    Cubbon, R.
    Miller, J. E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 717 - 717
  • [30] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey
    Viswabandya, Auro
    Kim, Dennis
    Thyagu, Santhosh
    Messner, Hans
    Michelis, Fotios
    BONE MARROW TRANSPLANTATION, 2018, 53 : 169 - 170
12345